Stemina Biomarker Discovery, Inc. has announced a $2.3 million investment from the Nancy Lurie Marks Family Foundation to support its clinical study of biomarkers in the blood of children with autism spectrum disorders that can distinguish them from typically developing children.

Read the full release here